反応 #340253

ord-e74c392ef6284cb09d0b8b2e987f8a6f

溶媒

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    workup.STIRRINGfurther stirred for 30 minutes
  2. 2
    ろ過filtered
  3. 3
    workup.DISTILLATIONThe filtrate was distilled at 50-55° C.
  4. 4
    workup.ADDITIONBenzene (10 mL) was added to the reaction mixture
  5. 5
    workup.DISTILLATIONdistilled at 90-95° C.
  6. 6
    workup.ADDITIONdi-isopropyl ether (20 mL) was added
  7. 7
    workup.STIRRINGstirred at 25-30° C. for 1 hour
  8. 8
    ろ過filtered
  9. 9
    workup.DISSOLUTIONwas dissolved in dichloromethane (25 mL)
  10. 10
    workup.DISTILLATIONdistilled under reduced pressure (5-10 mm)

実験手順

To a stirred suspension of clopidogrel base (3.83 g, 0.0119 mole) in water (3 mL) was added potassium hydrogen sulfate (1.62 g, 0.0119 mole) at 25-30° C. The reaction mixture was stirred for 15 minutes and acetone (25 mL) was added, further stirred for 30 minutes and filtered. The filtrate was distilled at 50-55° C. under reduce pressure (5-10 mm). Benzene (10 mL) was added to the reaction mixture and distilled at 90-95° C., di-isopropyl ether (20 mL) was added and stirred at 25-30° C. for 1 hour and filtered. The semi sold material was dissolved in dichloromethane (25 mL) and distilled under reduced pressure (5-10 mm) to give clopidogrel hydrogen sulfate (2.1 g). The amorphous form was similarly characterized by XRD, DSC, IR, chemical purity (HPLC)>99% and chiral purity (chiral HPLC) 99.5% (e.e.), % water 3.0, m.p. 94-98° C. (softens).

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US07872019B2uspto-grants-2011_01